Piramal approves $20m capacity expansion for hormonal, ADC manufacturing

By Zachary Brennan

- Last updated on GMT

Piramal approves $20m expansion for hormonal, ADC manufacturing

Related tags Manufacturing

Contract manufacturer Piramal recently approved a $20m capacity expansion for hormonal and antibody drug conjugate (ADC) manufacturing at its facilities in Morpeth, UK, and Grangemouth, Scotland.

The expansions come as the company also recently invested $40m in new equipment and technologies and related infrastructure. The company said the investments were part of a broader plan to better serve its customers.

On the ADC side, Piramal has invested steadily from a 2011 capacity expansion​ to a $2.5m expansion in 2013​.

In addition, the company recently completed a $10m green field facility to double its discovery services capacity.

Related topics Bio Developments

Related news

Show more

Follow us

Webinars